Dr. Oliver Dorigo on Ovarian Cancer - Current & Novel Treatment Strategies

Overview

Explore current and novel treatment strategies for ovarian cancer in this comprehensive lecture by Dr. Oliver Dorigo, Director and Associate Professor of the Division of Gynecologic Oncology at Stanford University Medical Center. Delve into the latest advancements in ovarian cancer diagnosis and specialized treatments based on cancer location and cellular anatomy. Learn about survival rates, the importance of initial surgery, modifications to conventional chemotherapy, and factors to consider in treating recurrent ovarian cancer. Discover targeted therapies, including DNA-repair mechanisms, tumor microenvironment interventions, and immunotherapy approaches such as blocking CD47 and adoptive cell transfer with genetically modified T cells. Gain valuable insights into the cutting-edge research and clinical applications being developed at Stanford's Women's Cancer Center to improve outcomes for ovarian cancer patients.

Syllabus

Intro
Five-year Relative Survival Rates for Ovarian, Cervical and Uterine Cancer 1996 - 2005
Ovarian Cancer Treatment Overview
The FIRST Surgery for Ovarian Cancer is the MOST IMPORTANT one!
Modifying Conventional Chemotherapy results in better Outcomes for Patients Japanese Gynecologie Oncology Group
Modifying Conventional Chemotherapy results in better Outcomes for Patients Japanese Gynecologic Oncology Group
Which Factors need to be considered in the Treatment of Recurrent Ovarian Cancer?
When does a second Surgery to remove Tumor Disease make sense?
Chemotherapy for Recurrent Ovarian Cancer
Ovarian Cancer Current and Novel Treatment Strategies
Targeted Killing of Cancer Cells With Defective DNA-Repair Mechanisms Double-stranded break
Cancer and the Surrounding Tissue (Tumor Microenvironment)
Blocking CD47 inhibits Tumor Growth in a Mouse Model of Ovarian Cancer
Directing the Immune System to Recognize and Attack Ovarian Cancer Cell
The Clinical Application of Adoptive Cell Transfer with Genetically Modified T Cells
Stanford Women's Cancer Center and Stanford Health Library Women & Cancer Quarterly Series